LEROZE Trademark

Trademark Overview

On Tuesday, June 2, 2009, a trademark application was filed for LEROZE with the United States Patent and Trademark Office. The USPTO has given the LEROZE trademark a serial number of 77749598. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 28, 2013. This trademark is owned by Glaxo Group Limited. The LEROZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
leroze

General Information

Serial Number77749598
Word MarkLEROZE
Filing DateTuesday, June 2, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 28, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 5, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, January 28, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 28, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 3, 2012EXTENSION 5 GRANTED
Tuesday, June 26, 2012EXTENSION 5 FILED
Tuesday, June 26, 2012TEAS EXTENSION RECEIVED
Tuesday, January 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2012EXTENSION 4 GRANTED
Tuesday, December 20, 2011EXTENSION 4 FILED
Tuesday, December 20, 2011TEAS EXTENSION RECEIVED
Friday, June 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2011EXTENSION 3 GRANTED
Wednesday, June 15, 2011EXTENSION 3 FILED
Wednesday, June 15, 2011TEAS EXTENSION RECEIVED
Wednesday, November 17, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 16, 2010EXTENSION 2 GRANTED
Thursday, November 11, 2010EXTENSION 2 FILED
Thursday, November 11, 2010TEAS EXTENSION RECEIVED
Wednesday, June 30, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 29, 2010EXTENSION 1 GRANTED
Thursday, June 3, 2010EXTENSION 1 FILED
Tuesday, June 29, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 3, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 29, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 6, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2009PUBLISHED FOR OPPOSITION
Monday, August 31, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 26, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 25, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, August 25, 2009ASSIGNED TO LIE
Tuesday, August 25, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 25, 2009PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
Tuesday, August 25, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 20, 2009ASSIGNED TO EXAMINER
Friday, June 5, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 5, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

leroze pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic